Keywords: حداقل بیماری باقی مانده; Adoptive immunotherapy chimerism; Minimal residual disease; Pediatric leukemia
مقالات ISI حداقل بیماری باقی مانده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Drug resistance; Drug tolerance; Genetically engineered mouse models; BRCA1; Cancer dormancy; Cancer stem cells; Autophagy; Microenvironment;
Keywords: حداقل بیماری باقی مانده; transplantacja komórek krwiotwórczych; marginalna choroba resztkowa; przewlekÅa biaÅaczka limfocytowa; Hematopoietic Stem Cell Transplantation; Minimal Residual Disease; Chronic Lymphocytic Leukemia;
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Chimerism; Allogeneic stem cell transplantation; Acute myeloid leukemia; Myelodysplastic syndrome; Relapse
Keywords: حداقل بیماری باقی مانده; High-risk SMM; MGUS; Minimal residual disease; Monoclonal protein; Plasma cells
Keywords: حداقل بیماری باقی مانده; Post-transplantation relapse; Leukemia; Risk factors; Minimal residual disease
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Mixed lineage leukemia (MLL) acute leukemia; Allogeneic hematopoietic stem cell transplantation
Keywords: حداقل بیماری باقی مانده; Relapse; Allogeneic hematopoietic cell transplantation; Pediatrics; Leukemia; Minimal residual disease
Keywords: حداقل بیماری باقی مانده; Chimerism; Minimal residual disease; Acute lymphoblastic leukemia; Stem cell transplantation; Relapse
Keywords: حداقل بیماری باقی مانده; Allogeneic transplantation; Autologous transplantation; Minimal residual disease; MIPI score; PET scan
Keywords: حداقل بیماری باقی مانده; acute promyelocytic leukaemia; PML-RARA; minimal residual disease; real-time quantitative; polymerase chain reaction; personalized medicine
Keywords: حداقل بیماری باقی مانده; Circulating myeloma clones; High-throughput sequencing; Immunoglobulin gene rearrangement; Minimal residual disease; Multiple myeloma;
Keywords: حداقل بیماری باقی مانده; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ASX; additional sex combs; BM; bone marrow; bZIP; leucine zipper; C/EBPα; CCAAT/enhancer binding protein α; CN-AML; normal karyotype-AML; CR; complete remissions; DFS; disease-free survival
Keywords: حداقل بیماری باقی مانده; BCR-ABL1; Clonogenic assay; Colony; Minimal residual disease; Tyrosine kinase inhibitor;
Keywords: حداقل بیماری باقی مانده; Complete molecular remission; Leukemic stem cells; Minimal residual disease; Treatment discontinuation; Tyrosine kinase inhibitors;
Keywords: حداقل بیماری باقی مانده; Acute leukemia; Minimal residual disease; Cytogenetics; Chromosome microdissection; Next-generation sequencing; Personalized medicine;
Keywords: حداقل بیماری باقی مانده; Neuroblastoma; Minimal residual disease; Mouse; Model; Resection
Keywords: حداقل بیماری باقی مانده; Chemotherapy; Dose intensification; Immunotherapy; Minimal residual disease; Targeted therapy
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Adults; High dose cytarabine; Minimal residual disease
High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; BCP-ALL; MLPA; Copy number abnormality; Minimal residual disease;
New rapid method to detect BCR-ABL fusion genes with multiplex RT-qPCR in one-tube at a time
Keywords: حداقل بیماری باقی مانده; Leukemia; BCR-ABL; Multiplex RT-qPCR; Fish; Minimal residual disease;
Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia
Keywords: حداقل بیماری باقی مانده; ALL; acute lymphoblastic leukemia; BM; bone marrow; MRD; minimal residual disease; CAB; cabazitaxel; PLI; plicamycin; NP; nanoparticles; PD; phase dim; B-cell acute lymphoblastic leukemia; Bone marrow microenvironment; Minimal residual disease; Drug resis
A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype
Keywords: حداقل بیماری باقی مانده; T-cell acute lymphoblastic leukemia; Minimal residual disease; Flow cytometry;
Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT
Keywords: حداقل بیماری باقی مانده; AlloHSCT; AutoHSCT; Ph-positive ALL; Tyrosine kinase inhibitors; Minimal residual disease; GvHD;
Minimal residual disease detection of myeloma using sequencing of immunoglobulin heavy chain gene VDJ regions
Keywords: حداقل بیماری باقی مانده; Next-generation sequencing; VDJ sequencing; Minimal residual disease; Myeloma;
Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukemia; Minimal residual disease; Flow cytometry; Next generation sequencing; Transplant; NPM1;
Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value
Keywords: حداقل بیماری باقی مانده; Leukemia; WT1; Molecular diagnostics; Minimal residual disease; Remission status; Hematopoietic stem cell transplantation;
SOHO State of the Art Update and Next Questions: Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Minimal residual disease; Philadelphia chromosome; Prognostic factors; Tyrosine kinase inhibitor;
The clinical significance of CDX2 in leukemia: A new perspective for leukemia research
Keywords: حداقل بیماری باقی مانده; CDX2; Leukemia; Prognosis; Minimal residual disease; Drug resistance;
BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Immune profiling; Multiple myeloma, autologous stem cell transplant;
IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukemia; IDH1 and IDH2 mutations; Minimal residual disease; NGS; ddPCR;
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis
Keywords: حداقل بیماری باقی مانده; ETV6/RUNX1-positive ALL; Childhood leukemia; FISH; ETV6/RUNX1 fusion gene; Cytogenetics; ALL; acute lymphoblastic leukemia; EFS; event-free survival; OS; overall survival; RFS; relapse-free survival; BM; bone marrow; SUB; subclones; mSUB; minor subclones;
Bispecific antibodies for cancer therapy: A review
Keywords: حداقل بیماری باقی مانده; ADCC; antibody-dependent cell-mediated cytotoxicity; AE; adverse events; ALL; acute lymphoblastic leukemia; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; B-ALL; B-cell acute lymphoblastic leukemia; BiTES; Bi-sp
Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell
Keywords: حداقل بیماری باقی مانده; NK cell; natural killer cell; IFN-γ; interferon-γ; IL; interleukin; TNF-α; tumor necrosis factor-α; CCL; C-C motif ligand; GM-CSF; granulocyte-macrophage colony-stimulating factor; ADCC; antibody dependent cell-mediated cytotoxicity; TRAIL; TNF-relate
Research paperA rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD)
Keywords: حداقل بیماری باقی مانده; e13a3 (b2a3) BCR-ABL1 Fusion Transcript; Normal karyotype; Chronic myeloid leukemia; Minimal residual disease;
Ekspresja CD10 na minimalnych komórkach resztkowych u dzieci z ostrÄ
biaÅaczkÄ
limfoblastycznÄ
B-komórkowÄ
Keywords: حداقل بیماری باقی مانده; minimalna choroba resztkowa; ostra biaÅaczka limfoblastyczna; cytometrii przepÅywowa; terapia prednizonem; ekspresja CD10; Minimal residual disease; Acute lymphoblastic leukemia; Flow cytometry; Prednisone therapy; CD10 expression;
Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument “Pro”
Keywords: حداقل بیماری باقی مانده; ALL; Hematopoetic cell transplantation; Minimal residual disease; Philadelphia chromosome; Tyrosine kinase inhibitors;
Brief ArticlesNext-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Minimal residual disease;
Ãtude du chimérisme après allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
Keywords: حداقل بیماری باقی مانده; Chimérisme; PCR quantitative; Maladie résiduelle; Sang; Chimerism; Real time PCR; Minimal residual disease; Blood;
Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukemia; Age; AML; Azacitidine; Clofarabine; Consolidation; CPX-351; Cytarabine; Cytogenetics; Daunorubicin; Decitabine; Minimal residual disease; MRD; Reduced intensity conditioning; RIC; Risk; TP53; Transplant;
Original ArticlesInfluence of Musculoskeletal Manifestations as the Only Presenting Symptom in B-Cell Acute Lymphoblastic Leukemia
Keywords: حداقل بیماری باقی مانده; children; symptom duration; limb pain; overall survival; ALL; Acute lymphoblastic leukemia; B-ALL; B-cell type acute lymphoblastic leukemia; HR; Hazard ratio; MRD; Minimal residual disease; NCI; National Cancer Institute; WBC; White blood cell;
Research paperPost-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: A retrospective cohort study
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukemia; Minimal residual disease; WT1 overexpression; Induction treatment; Allogeneic stem cell transplantation;
IFN-α Is Effective for Treatment of Minimal Residual Disease in Patients with Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Registry Study
Keywords: حداقل بیماری باقی مانده; Preemptive; Interferon-α; Hematopoietic stem cell transplantation; Minimal residual disease;
Allogeneic: AdultMulticolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Flow cytometry; Next-generation sequencing; Acute myeloid leukemia;
Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary acute myeloid leukemia in first remission
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukemia; Cytogenetic classification; Minimal residual disease; Autologous stem cell transplantation; Allogeneic stem cell transplantation;
Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients
Keywords: حداقل بیماری باقی مانده; AML with normal karyotype; Minimal residual disease; Prognosis; Real-time PCR; WT1 expression;
Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes
Keywords: حداقل بیماری باقی مانده; B-precursor acute lymphoblastic leukemia; flow cytometry; fusion transcripts; minimal residual disease;
Hematologic neoplasms: Dendritic cells vaccines in motion
Keywords: حداقل بیماری باقی مانده; DCs; dendritic cells; TAA; tumor-associated antigens; APC; antigen presenting cells; mDCs; myeloid dendritic cells; pDCs; plasmacytoid dendritic cells; HLA; human leukocyte antigen; Ag Antigens; abs antibodies; PBMCs; peripheral blood mononuclear cells; G
How do we measure MRD in ALL and how should measurements affect decisions. Re: Treatment and prognosis?
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Minimal residual disease; Flow cytometry; Quantitative PCR; Next generation sequencing;
How should we treat a patient with relapsed Ph-negative B-ALL and what novel approaches are being investigated?
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Relapse; Minimal residual disease; Antibodies; Immunotherapy;